Stomach neoplasm
Showing 26 - 50 of 2,324
ValidateRisk Scoring Model for HMGC After Curative Surgery
Not yet recruiting
- Predictive Cancer Model
- +2 more
-
Tianjin, 天津, ChinaCancer Hospital of Tianjin Medical University
Sep 5, 2023
Stomach Tumor Trial (durvalumab and vactosertib)
Not yet recruiting
- Stomach Neoplasm
- durvalumab and vactosertib
- (no location specified)
May 14, 2021
Circular and Linear Stapler for Intracorporeal
Recruiting
- Stomach Neoplasm
- Esophagojejunostomy type
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Aug 9, 2021
Stomach Tumor Trial in Italy, Netherlands, United Kingdom (Gastrectomy)
Not yet recruiting
- Stomach Neoplasm
- Gastrectomy
-
Siena, Italy
- +14 more
Dec 18, 2021
Tumor, Stomach, Gastric Tumors Malignant, Pancreatic Tumors Trial in Bogotá (Petiveria Alliacea Preparation, Placebo)
Not yet recruiting
- Neoplasm, Stomach
- +8 more
- Petiveria Alliacea Preparation
- Placebo
-
Bogotá, ColombiaPontificia Universidad Javeriana
Oct 16, 2022
Gastrointestinal Anastomosis Using MonoPlus® Suture
Recruiting
- Gastrointestinal Stromal Tumors
- +6 more
-
Sabadell, Cataluña, Spain
- +1 more
Jan 31, 2023
Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine
Not yet recruiting
- Digestive System Neuroendocrine Tumor G1
- +5 more
- Tumor Debulking
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 23, 2023
Stomach Tumor, Peritoneal Metastases Trial in Seongnam (Pressurized Intraperitoneal Aerosol Chemotherapy)
Recruiting
- Stomach Neoplasm
- Peritoneal Metastases
- Pressurized Intraperitoneal Aerosol Chemotherapy
-
Seongnam, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Jun 1, 2021
Gastric Cancer Trial (HIPEC,anti-PD-1 antibody Sintilimab (Tyvyt®), Chemotherapy,Surgery)
Not yet recruiting
- Gastric Cancer
- HIPEC,anti-PD-1 antibody Sintilimab (Tyvyt®), Chemotherapy,Surgery
- (no location specified)
Dec 14, 2022
Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Jinan (CEA CAR-T cells)
Recruiting
- Colorectal Cancer
- +5 more
- CEA CAR-T cells
-
Jinan, Shandong, ChinaThe Second People's Hospital of Shandong Province
Jul 19, 2022
Liver Metastases Trial in Hangzhou (Tislelizumab in Combination with Oxaliplatin and Tegafur)
Recruiting
- Liver Metastases
- Tislelizumab in Combination with Oxaliplatin and Tegafur
-
Hangzhou, Zhejiang, Chinagastrointestinal department of second affiliated hospital of Zhe
Jan 31, 2023
Stomach Tumors, Interleukin, Stomach Cancer Trial in Debrecen (Partial omentectomy)
Recruiting
- Stomach Neoplasms
- +4 more
- Partial omentectomy
-
Debrecen, Hajdú - Bihar, HungaryUniversity of Debrecen - Surgical Clinic
May 16, 2022
Stomach Tumors, Peritoneal Metastases Trial (HIPEC, Paclitaxel-albumin, Tegafur-gimeracil-oteracil potassium)
Not yet recruiting
- Stomach Neoplasms
- Peritoneal Metastases
- HIPEC
- +3 more
- (no location specified)
Oct 26, 2021
Gastric Polyp, Gastric Tumor, Duodenal Tumors Trial in Be'er Ya'aqov (Tranexamic acid, Epinephrine injection)
Not yet recruiting
- Gastric Polyp
- +3 more
- Tranexamic acid
- Epinephrine injection
-
Be'er Ya'aqov, IsraelShamir Medical Center
Jan 8, 2023
Multiple Coagulation-related Factors and Lymph Node Metastasis
Recruiting
- Gastric Cancer Stage
- Lymph Node Metastasis
- coagulation-related factors
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Oct 21, 2022
Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)
Recruiting
- Stage II-III Gastric Cancer
- MRD-guided therapy
-
Jinan, Shandong, China
- +4 more
Nov 27, 2023
Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Hangzhou (CEA CAR-T cells)
Recruiting
- Colorectal Cancer
- +5 more
- CEA CAR-T cells
-
Hangzhou, Zhejiang, ChinaFirst affiliated hospital, Zhejiang University
May 30, 2022
Genomic Evolution of Metastasis in Gastric Cancer
Recruiting
- Gastric Cancer
- Metastasis
-
Ho Chi Minh City, VietnamUniversity Medical Center Ho Chi Minh City
Apr 27, 2022
Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
- Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 18, 2023
Psychological, Psychophysical and Epigenetic Determinants of
Recruiting
- Appendix Carcinoma
- +5 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 28, 2022
Preoperative Immunonutrition in Laparoscopic Total D2
Completed
- Gastric Cancer
- +4 more
- immunonutrition
- (no location specified)
Feb 17, 2022
Gastric Cancer, Peritoneal Metastases Trial in Rotterdam (Irinotecan, CAPOX)
Recruiting
- Gastric Cancer
- Peritoneal Metastases
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 15, 2022
Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection Trial in Goyang (7 day H.pylori eradication Omeprazole
Active, not recruiting
- Helicobacter Pylori Infection
- +2 more
- 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin
- Placebo, Omeprazole or Rabeprazole, Clarithromycin
-
Goyang, Gyeonggi, Korea, Republic ofNational Cancer Center, Korea
Apr 8, 2022